Company · CIK 1652923
AveXis, Inc.
| CIK | 1652923 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | IL |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2016-03-18 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-216814 | 2017-03-17 | 2018-05-22 | 6 | |
| 333-213292 | 2016-08-24 | 2016-09-12 | 4 | |
| 333-209019 | 2016-01-15 | 2016-02-11 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2018-05-22 | EFFECTDeclared effective | 333-216814 | 9999999995-18-001305 |
| 2018-01-18 | 424B5Shelf takedown | 333-216814 | 0001047469-18-000252 |
| 2018-01-16 | 424B5Shelf takedown | 333-216814 | 0001047469-18-000193 |
| 2017-06-22 | 424B5Shelf takedown | 333-216814 | 0001047469-17-004177 |
| 2017-06-19 | 424B5Shelf takedown | 333-216814 | 0001047469-17-004098 |
| 2017-03-17 | S-3ASRShelf registered | 333-216814 | 0001047469-17-001757 |
| 2016-09-12 | 424B4Final prospectus | 333-213292 | 0001047469-16-015407 |
| 2016-09-07 | EFFECTDeclared effective | 333-213292 | 9999999995-16-005631 |
| 2016-09-06 | S-1/AAmendment | 333-213292 | 0001047469-16-015273 |
| 2016-08-24 | S-1Registration filed | 333-213292 | 0001047469-16-015110 |
| 2016-02-11 | 424B4Final prospectus | 333-209019 | 0001047469-16-010121 |
| 2016-02-10 | EFFECTDeclared effective | 333-209019 | 9999999995-16-003724 |
| 2016-02-09 | S-1/AAmendment | 333-209019 | 0001047469-16-010062 |
| 2016-02-01 | S-1/AAmendment | 333-209019 | 0001047469-16-009943 |
| 2016-01-15 | S-1Registration filed | 333-209019 | 0001047469-16-009715 |
| 2015-10-16 | DRSDraft made public | 377-01176 | 0000912057-15-000357 |